Navigation Links
Isis Reports Positive Results of Phase 2 Study of ISIS 301012 in Heterozygous FH Patients
Date:10/4/2007

- HeFH Patients on Maximally Tolerated Lipid-Lowering Therapies Experienced 46% Further Reductions in LDL-C when Treated with 300 mg/week ISIS 301012

for 13 Weeks - Study Presented in Poster Session Today at DALM Symposium in New York

City - Isis Will Host a Conference Call on Monday, October 8, at 8:00 a.m. E.T.

at http://www.isispharm.com

CARLSBAD, Calif., Oct. 4 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced new results from its Phase 2 clinical trial of ISIS 301012 in patients with heterozygous familial hypercholesterolemia (HeFH) on stable maximally tolerated lipid-lowering therapies presented in a poster session today at the Drugs Affecting Lipid Metabolism (DALM) XVI International Symposium in New York City. These results will also be presented by Dr. John J.P. Kastelein in an oral session at DALM on Saturday at 3:45 p.m. E.T., and Isis will host a conference call Monday morning at 8:00 a.m. E.T. to further discuss the results.

In a randomized, double-blind, placebo-controlled study, HeFH patients being treated with maximally tolerated lipid-lowering therapies were treated with ISIS 301012 for 6 or 13 weeks. Median baseline LDL-C levels for the dose cohorts ranged from 159 - 204 mg/dL. ISIS 301012 add-on treatment produced potent, dose-dependent, prolonged reductions in all atherogenic lipids, and results were consistent with those reported for patients with routine high cholesterol. Furthermore, this study confirmed that ISIS 301012 treatment results in meaningful reductions in Lp(a), another important predictor of
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... YORK , Feb. 27, 2015 Securities ... the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... $158.00 per share. Concerned SLXP investors are encouraged to ... The investigation focuses upon the shareholder ... agreement, Salix shareholders would receive only $158.00 per share ...
(Date:2/27/2015)... 27, 2015  Boston Scientific Corporation (NYSE: ... 2015 Annual Healthcare Conference on March 10 in ... Brennan , executive vice president and chief financial officer, ... will participate in a 25-minute question and answer session ... 1:05 p.m. ET. Following a 5-minute break, a question ...
(Date:2/27/2015)... Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" ... today announced financial results for its first quarter ended ... months ended December 31, 2014, revenue was $1,336,685. Operating ... $229,820 or $0.02 per share.  Covalon,s ... am very pleased with the significant progress we have ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3
... It may seem as if new developments to combat ... of light. At the forefront of the research, dermatologists ... how the skin ages in order to develop more effective ... laser light – used successfully for years to make skin ...
... Anomatic Corporation, known for their unique, high volume ... medical, pharmaceutical, personal care and cosmetic packaging industries, is ... 1.2 million dollars to build a comprehensive ... capacity. This capacity increase includes 10 new metal stamping ...
Cached Medicine Technology:Electricity Sparks Interest in New Technologies and Cosmeceuticals for Aging Skin 2Electricity Sparks Interest in New Technologies and Cosmeceuticals for Aging Skin 3Electricity Sparks Interest in New Technologies and Cosmeceuticals for Aging Skin 4Anodizing Leader Expands Capacity at U.S. Facility 2
(Date:2/27/2015)... honor of American Heart Month in February, Dr. Edwin Scott, from ... on how to improve heart health. , Heart disease may be ... to accept it as their fate. Although one may lack the ... sex or age — there are some key heart disease prevention ... to improve heart health and prevent heart disease: , 1. Don't ...
(Date:2/27/2015)... ME (PRWEB) February 27, 2015 Royal River ... ME, reports a new study that found adults who got ... develop type 2 diabetes compared to those who got the ... blood sugar levels. , The report is part of the ... ,” which Royal River Natural Foods publishes free each month ...
(Date:2/27/2015)... 27, 2015 Adding to its ... pharmaceuticals, Benedict Advertising & Marketing has added Sedation ... The company’s patented NITROUSEAL® N20 closed mask and ... of sedation. , Sedation Systems, http://www.sedationsystems.com ... a new level, though it focuses primarily on ...
(Date:2/27/2015)... 27, 2015 FACE Skincare~Medical~Wellness, a ... announced a unique combination to take fifteen years ... Décolletage is a new treatment introduced that is ... specifically indicated to improve lines and wrinkles on ... person who suffers from the stubborn vertical lines ...
(Date:2/27/2015)... Nashville, TN (PRWEB) February 27, 2015 ... Oral Health, has announced a scholarship for rising freshmen ... is Nashville’s leading periodontist office specializing in many periodontal ... , and treatment of gum disease . In ... single $1,000 college scholarship for eligible rising freshmen undergraduate ...
Breaking Medicine News(10 mins):Health News:Center for Primary Care Celebrates American Heart Month 2Health News:Center for Primary Care Celebrates American Heart Month 3Health News:Center for Primary Care Celebrates American Heart Month 4Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Face Skincare Announces New Combination Therapy 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2
... 40 per cent of colon and breast,cancer cases in ... activity and weight maintenance, according to estimates in a,report ... to prevent,cancer. , The report, ... Cancer Research Fund (WCRF) and American Institute for Cancer ...
... WHITE PLAINS, N.Y., Feb. 26 Stress levels are ... starting to take a toll on many people. To ... their heads over it. In fact, daily stress can ... as seborrheic dermatitis, psoriasis and eczema. (Photo: http://www.newscom.com/cgi-bin/prnh/20090226/NYFNSH02 ...
... Maintain Compliance and Make Patient Safety a PriorityPORTLAND, ... recession has healthcare payers caught between member demands ... costs, while they also wrestle with business restructuring, ... expense and complexity of new technologies, treatments and ...
... Glenwood Systems, LLC ( http://www.GlenwoodSystems.com ) launches the GlaceComplete product suite ... to an assisted medical billing process. The product has ... inefficiency while maximizing revenue contribution for the average office based medical ... ...
... one-time $250 bonus coming from $787 billion national stimulus package ... ... can look forward to receiving a one-time $250 bonus payment by ... thousands of people in the Social Security Disability Insurance ...
... N.Y., Feb. 26 ABC,s hit television series Extreme ... (ET) episode on a March of Dimes volunteer family ... prematurely and whose home was later destroyed by a flood. ... in less than a week,s time during the taping of ...
Cached Medicine News:Health News:Landmark Report: Many Cancers Could be Prevented 2Health News:Recession Got You Scratching Your Head, New Scalpicin(R) Anti-Itch Wipes Can Help 2Health News:Independent Review Organizations Take Pressure Off Healthcare Payers as Recession Deepens 2Health News:Independent Review Organizations Take Pressure Off Healthcare Payers as Recession Deepens 3Health News:Glenwood Systems, LLC Improves Medical Billing Process with GlaceComplete 2Health News:Glenwood Systems, LLC Improves Medical Billing Process with GlaceComplete 3Health News:Social Security Disability Insurance Recipients To Get Extra $250 By Summer 2Health News:Social Security Disability Insurance Recipients To Get Extra $250 By Summer 3Health News:Social Security Disability Insurance Recipients To Get Extra $250 By Summer 4Health News:ABC's Extreme Makeover: Home Edition Gives Parents of Preemie a New Home 2
... immobilization following shoulder fusion, dislocation, reconstruction ... allows the shoulder to be positioned ... Following brachial plexus injury this orthosis ... stretch during the healing process and ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... of acute low back pain, they want ... restores functional mobility by providing powerful compression ... sizes that correspond directly to men's or ... reduce inventory requirements while simplifying the fitting ...
Medicine Products: